Search by Drug Name or NDC

    NDC 63868-0864-20 DayTime Cold and Flu 325; 10; 5 mg/1; mg/1; mg/1 Details

    DayTime Cold and Flu 325; 10; 5 mg/1; mg/1; mg/1

    DayTime Cold and Flu is a ORAL CAPSULE, LIQUID FILLED in the HUMAN OTC DRUG category. It is labeled and distributed by Chain Drug Marketing Association Inc.. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63868-0864
    Product ID 63868-864_20a71d90-e509-4a22-a497-e05f265ac6ad
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name DayTime Cold and Flu
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 325; 10; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Chain Drug Marketing Association Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 63868-0864-20 (63868086420)

    NDC Package Code 63868-864-20
    Billing NDC 63868086420
    Package 2 BLISTER PACK in 1 CARTON (63868-864-20) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
    Marketing Start Date 2017-03-08
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL ee89b666-7c5d-4f52-9df4-d14b04fb46ae Details

    Revised: 12/2019